Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages 617-623

  Quon, Harvey ^a,b   Cheung, Patrick C F ^a,b   Loblaw, D Andrew ^a,b   Morton, Gerard ^a,b   Pang, Geordi ^a,b   Szumacher, Ewa ^a,b   Danjoux, Cyril ^a,b   Choo, Richard ^c   Kiss, Alex ^a   Mamedov, Alexandre ^a   Deabreu, Andrea ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MAYO CLINIC   (United States)

Author keywords

Hypofractionation; Intensity modulated radiotherapy; Prostatic neoplasms; Quality of life; Radiotherapy

Indexed keywords

BOWEL TOXICITY; EXPANDED PROSTATE CANCER INDEX COMPOSITES; FIDUCIALS; GLEASON SCORES; GOLD SEEDS; HEALTH-RELATED QUALITY OF LIVES; HYPOFRACTIONATION; IMAGE GUIDANCES; INTENSITY-MODULATED RADIOTHERAPY; LONG-TERM ANDROGEN DEPRIVATION; PELVIC LYMPH NODES; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

DISEASES; TOXICITY; UROLOGY;

RADIOTHERAPY;

BICALUTAMIDE; BUSERELIN ACETATE; GOSERELIN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT TOOL; DYSURIA; EXPANDED PROSTATE CANCER INDEX COMPOSITE; FECES INCONTINENCE; FOLLOW UP; FUNCTIONAL STATUS; GLEASON SCORE; HEMATOCHEZIA; HEMATURIA; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SCORING SYSTEM; SEXUAL DYSFUNCTION; URINARY TRACT OBSTRUCTION; URINARY URGENCY; URINE INCONTINENCE;

AGED; ANDROGEN ANTAGONISTS; DOSE FRACTIONATION; FEMUR HEAD; HUMANS; MALE; NEOPLASM STAGING; ORGANS AT RISK; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RISK; URINARY BLADDER;

EID: 84861097840     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.07.005     Document Type: Article

References (31)

1. Canadian Cancer Society Canadian cancer statistics 2009 2009 Canadian Cancer Society Toronto
2. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J M 358 2008 1250 1261 (Pubitemid 351439226)
3. R.C. Chen, J.A. Clark, and J. Manola Treatment 'mismatch' in early prostate cancer: Do treatment choices take patient quality of life into account? Cancer 112 2008 61 68
4. Y. Pardo, F. Guedea, and F. Aguilo Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment J Clin Oncol 28 2010 4687 4696
5. D.J. Brenner, and E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1101 (Pubitemid 29144800)
6. Miralbell R, Roberts SA, Zubizarreta E, et al. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys. In press.
7. P.A. Kupelian, T.R. Willoughby, and C.A. Reddy Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424 1430 (Pubitemid 47176809)
8. J.M. Martin, T. Rosewall, and A. Bayley Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma Int J Radiat Oncol Biol Phys 69 2007 1084 1089 (Pubitemid 47625844)
9. S.L. Faria, L. Souhami, and B. Joshua Reporting late rectal toxicity in prostate cancer patients treated with curative radiation treatment Int J Radiat Oncol Biol Phys 72 2008 777 781
10. H. Tsuji, T. Yanagi, and H. Ishikawa Hypofractionated radiotherapy with carbon ion beams for prostate cancer Int J Radiat Oncol Biol Phys 63 2005 1153 1160 (Pubitemid 41505295)
11. P.A. Kupelian, C.A. Reddy, and E.A. Klein Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life Int J Radiat Oncol Biol Phys 51 2001 988 993 (Pubitemid 33026429)
12. J.H. Coote, J.P. Wylie, and R.A. Cowan Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: Analysis of toxicity Int J Radiat Oncol Biol Phys 74 2009 1121 1127
13. M.S. Litwin, D.P. Lubeck, and J.M. Henning Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database J Urol 159 1998 1988 1992 (Pubitemid 29190741)
14. Quon H, Cheung PC, Loblaw DA, et al. Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: Late toxicity. Int J Radiat Oncol Biol Phys. In press.
15. T.S. Lim, P.C. Cheung, and D.A. Loblaw Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: Acute toxicity results Int J Radiat Oncol Biol Phys 72 2008 85 92
16. P. Cheung, K. Sixel, and G. Morton Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer Int J Radiat Oncol Biol Phys 62 2005 418 425 (Pubitemid 40704458)
17. H.A. Shih, M. Harisinghani, and A.L. Zeitman Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy Int J Radiat Oncol Biol Phys 63 2005 1262 1269 (Pubitemid 41505308)
18. A. Hsu, T. Pawlicki, and G. Luxton A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes Int J Radiat Oncol Biol Phys 68 2007 898 902 (Pubitemid 46818765)
19. J.T. Wei, R.L. Dunn, and M.S. Litwin Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
20. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation Med Care 41 2003 582 592
21. J.A. Talcott, J.A. Clark, and J. Manola Bringing prostate cancer quality of life research back to the bedside: Translating numbers into a format that patients can understand J Urol 176 4 Pt 1 2006 1558 1563 discussion 1563-1564
22. D.W. Bruner, C.J. Bryan, and N. Aaronson Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the national cancer institute-sponsored clinical trials networks J Clin Oncol 25 2007 5051 5057 (Pubitemid 350232283)
23. R.C. Chen, J.A. Clark, and J.A. Talcott Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function J Clin Oncol 27 2009 3916 3922
24. J.E. Livsey, J. Routledge, and M. Burns Scoring of treatment-related late effects in prostate cancer Radiother Oncol 65 2002 109 121 (Pubitemid 35346557)
25. J.L. Gore, K. Gollapudi, and J. Bergman Correlates of bother following treatment for clinically localized prostate cancer J Urol 184 2010 1309 1315
26. E.E. Yeoh, R.H. Holloway, and R.J. Fraser Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase iii randomized trial Int J Radiat Oncol Biol Phys 66 2006 1072 1083 (Pubitemid 44633501)
27. Lent SomA tables Radiother Oncol 35 1995 17 60
28. J.L. Speight, E.P. Elkin, and D.J. Pasta Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: Data from CaPSURE Int J Radiat Oncol Biol Phys 60 2004 1066 1075 (Pubitemid 39440790)
29. M. Gacci, A. Simonato, and L. Masieri Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy Health Qual Life Outcomes 7 2009 94
30. L.R. Schover, R.T. Fouladi, and C.L. Warneke Defining sexual outcomes after treatment for localized prostate carcinoma Cancer 95 2002 1773 1785
31. J.T. Wei, R.L. Dunn, and H.M. Sandler Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer J Clin Oncol 20 2002 557 566 (Pubitemid 34072540)